Development of Kanghong Pharmaceutical Group

In April 2009, Chengdu Kanghong Pharmaceutical Group Kanghong trademark was recognized as a well-known trademark in China by the State Administration for Industry and Commerce.

2009- 1 Chengdu Kanghong Pharmaceutical Group won the 30-year Innovation Award of China Pharmaceutical Reform and Opening-up.

2008- 1 1 The biomacromolecule protein drug laboratory of Chengdu Kanghong Pharmaceutical Group was recognized as the key laboratory of Sichuan Province.

2008- 10 In the first batch of credit evaluation of national pharmaceutical enterprises organized by China Chemical Pharmaceutical Industry Association, Chengdu Kanghong Pharmaceutical Group became one of the only seven pharmaceutical enterprises in China to obtain AAA corporate credit rating, and it was also the only credit granting enterprise in our province.

In May 2008, the production base of Chengdu Kanghong Biological Co., Ltd., a major project in Chengdu, broke ground. The project will build four national first-class new drug production lines that meet the standards of China GMP, EU EMEA GMP and US cGMP.

In February 2008, the construction project of Kanghong Jinsai (Chengdu) Pharmaceutical Co., Ltd. officially started. After the project is completed, it is expected to become the first pharmaceutical production base in the Asia-Pacific region to adopt isolated and fully enclosed production technology.

In August 2007, the conceptual design of Kanghong Jinsai (Chengdu) Pharmaceutical Co., Ltd. passed the FDA certification.

In July, 2007, Chengdu Kanghong Pharmaceutical Group entered the list of cultivating large enterprises in Sichuan Province.

2007-6 Chengdu Hongda Pharmaceutical Co., Ltd. was established.

2007-5 Shanghai Kanghong VIOS Biotechnology Co., Ltd. was established.

2006- 12 Chengdu Kanghong Pharmaceutical Group and American Jinsai Pharmaceutical Co., Ltd. held the signing ceremony of the joint venture project between Chengdu Kanghong Pharmaceutical Group and American Jinsai Pharmaceutical Co., Ltd. in Kanghong Science and Technology Building, with each party contributing 50%, and Kanghong Jinsai (Chengdu) Pharmaceutical Co., Ltd. was formally established.

In September 2006, Chengdu Kanghong Pharmaceutical Group Enterprise Technology Center was jointly recognized by the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Finance, the General Administration of Customs and State Taxation Administration of The People's Republic of China as a nationally recognized enterprise technology center.

2005- 12 Chengdu kanghong biotechnology co., ltd was established.

2005-8 Kanghong Science and Technology Building, the office building of the group headquarters, was completed and put into use.

2003- 12 Chengdu kanghong pharmaceutical trading co., ltd was established.

In June 2003, Sichuan Kanghong Pharmaceutical Trading Co., Ltd. passed the national GSP certification.

200 1-9 Sichuan Jishengtang Pharmaceutical Co., Ltd. was restructured and established.

2000- 1 1 Established Kanghong Postdoctoral Research Center with the approval of the Ministry of Personnel.

1999- 1 The R&D Department Development Center of Chengdu Kanghong Pharmaceutical Group was rated as a provincial technology center by the Sichuan provincial government.

1998- 12 The production system of Chengdu Kanghong Pharmaceutical Co., Ltd. has all passed the GMP certification organized by the State Administration of Pharmaceutical Products and obtained the first GMP certificate issued by the State Administration of Pharmaceutical Products (A000 1).

1998- 12 Chengdu southwest pharmaceutical co., ltd was established.

1998- 1 1 Sichuan kanghong pharmaceutical trading co., ltd was established.

1998-6 branch Committee of Chengdu kanghong pharmaceutical co., ltd was established.

1996- 12 The Shuangliu new production base of Chengdu Kanghong Pharmaceutical Co., Ltd. was officially put into production.

1996- 12 Chengdu kanghong pharmaceutical co., ltd. has an annual sales return of over 100 million yuan.

1995- 1 Chengdu kanghong pharmaceutical co., ltd. officially received the pharmaceutical manufacturing enterprise license.

1994-8 Chengdu kanghong pharmaceutical co., ltd was established. social responsibility

The growth of enterprises can not be separated from the help of society, and the harmonious progress of society also needs the participation of enterprises. Since 16, Kang Hong has donated cash and materials to all walks of life for disaster relief, school construction, scholarships, regional disease prevention, economic and cultural assistance in poverty-stricken areas, etc. Kanghong fulfilled his promise of prosperity and benefit for all living beings with practical actions.

Since 2005, Kang Hong has established Fudan University Kang Hong Medical Scholarship in Fudan University. Since 2006, Kang Hong has donated RMB 1.25 million to Sichuan University to establish Kang Hong Scholarship and Kang Hong Scholarship of Sichuan University.

In 2008, during the May12 Wenchuan earthquake, Kanghong, as a disaster-stricken enterprise, donated more than 5 million yuan worth of cash, medicines and relief materials to the disaster area, and actively participated in the reconstruction of Yuexiu Friendship Hospital in Yingxiu Town, Wenchuan, the first hospital in the disaster area.

On April 201April 0 14, an earthquake of magnitude 7. 1 occurred in Yushu, Qinghai. Kang Hong, who experienced the 512 earthquake, felt the same way. In order to support post-disaster reconstruction, Kang Hong immediately donated 1.86 million yuan in cash and materials to the earthquake-stricken areas through the Sichuan Red Cross Society.

On June 8, 20 10, Kang Hong donated 500,000 yuan to Sichuan Care for the Next Generation Foundation. Become one of the first enterprises (individuals) supported by the Foundation.

Kanghong Pharmaceutical Group will, as always, adhere to the corporate purpose of prosperity, prosperity and benefit for all beings, adhere to the development path of professional innovation, and continue to devote itself to developing high-quality and high-tech pharmaceutical products, serving public health, promoting industry progress and repaying social care!